CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Testicular Cancer

Consultant. Vol. 48 No. 13
Photoclinic
Foresee Your Next Patient 

Metastatic Testicular Cancer

By SUDHIR R. GOGU, DO and SUJAN GOGU, BS
San Antonio, Tex | December 1, 2008

A 24-year-old man presented to the emergency department with worsening dyspnea and fever of 1 day’s duration. About 3 years earlier, he had been treated for testicular cancer (leiomyosarcoma) with orchidectomy, chemotherapy, and radiation. He had no significant social or family history.

Temperature was 38.6°C (101.4°F); blood pressure, 119/80 mm Hg; heart rate, 121 beats per minute; and respiration rate, 20 breaths per minute. Oxygen saturation measured with pulse oximetry was 98% with a nonrebreather mask and about 80% without a nonrebreather mask. Breath sounds were decreased bilaterally. The abdomen was soft. Extremities were nonedematous. Neurological findings were intact with no focal deficits.

The white blood cell count was 12,800/μL, hemoglobin level was 9.8 g/dL, hematocrit was 30.8%. Results of a complete metabolic profile were normal, except for the following levels: sodium, 131 mEq/L; albumin, 2.6 g/dL; and calcium, 11.8 mg/dL. An ECG showed sinus tachycardia with a heart rate of 120 beats per minute.

A chest radiograph revealed complete opacification of the right lobe and partial opacification with infiltrate of the left lung, suggestive of acute pneumonia. Metastasis of the testicular cancer to the lungs was suspected. The patient was transferred to a tertiary care center for further evaluation and treatment by an oncologist. Further testing, including thoracentesis, confirmed the metastasis.

In the United States, 16,580 cases of testicular cancer were diagnosed in men aged 15 to 49 years between 1975 and 2004.1 Although cure rates are high among treated patients, testicular cancer survivors appear to be at increased risk for the development of malignant tumors for at least 35 years after treatment.2 Testicular leiomyosarcoma is extremely rare and has the potential for distant metastases.3

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES:
1. Holmes L Jr, Escalante C, Garrison O, et al. Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? Public Health. 2008; 122:862-872.
2. Travis LB, Fosså SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97: 1354-1365.
3. Singh R, Chandra A, O’Brien TS. Primary intratesticular leiomyosarcoma in a mixed race man: a case report. J Clin Pathol. 2004;57:1319-1320.


 
RELATED CONTENT

Metabolic Syndrome After Hormone-Modifying Therapy: Risks Associated With Antineoplastic Therapy
ONCOLOGY,  August 24, 2010
Sonography better to monitor small testicular lesions
Oncology NEWS International,  August 10, 2010
The Approach to the Patient With Synchronous Bilateral Germ Cell Tumors: A Lesson in Oncologic Prioritization
ONCOLOGY,  July 21, 2010
Simultaneously Detected Bilateral Testicular Cancer of Different Histopathological Origin
ONCOLOGY,  July 21, 2010
Cancer Management Chapter 15: Testicular cancer
Cancer Management: A Multidisciplinary Approach, 12th Edition (2009),  March 12, 2010
 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • Head and Neck Tumors
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


CancerNetwork on Facebook

 

 
SEARCHMEDICA SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Testicular Cancer
Evidence on Testicular Cancer
Guidelines on Testicular Cancer
Patient Education on Testicular Cancer
Clinical Trials on Testicular Cancer
Practical Articles on Testicular Cancer
Research and Reviews on Testicular Cancer
All "Testicular Cancer" results

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy